A controlled trial of a critical pathway for treatment of community- acquired pneumonia

JAMA

Volumn 283, Issue 6, 2000, Pages 749-755

  Marrie, Thomas J ^a   Lau, Catherine Y ^b   Wheeler, Susan L ^b   Wong, Cindy J ^c   Vandervoort, Margaret K ^c   Feagan, Brian G ^c,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Janssen Ortho Inc   (Canada)

^c Queen's Cancer Research Institute   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CANADA; CLINICAL PATHWAY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EMPYEMA; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SEPSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0033974755     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.6.749     Document Type: Article

References (35)

1. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. 1995;333:1618-1624.
2. Fine MJ, Singer DE, Phelps AL, Hanusa BH, Kapoor WN. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care. 1993;31:371-380.
3. Gilbert K, Gleason PP, Singer DE, et al. Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia. Am J Med. 1998;104:17-27.
4. Weingarten SR, Riedinger MS, Hobson P, et al Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med. 1996; 153:1110-1115.
5. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:134-141.
6. Niederman MS, McCombs J, Linger A, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther. 1998;20:820-836.
7. Ellrodt G, Cook DJ, Lee J, et al. Evidence-based disease management. JAMA. 1997;278:1687-1692.
8. Weingarten SR, Riedinger MS, Varis G, et al. Identification of low-risk hospitalized patients with pneumonia. Chest. 1994;105:1109-1115.
9. Pearson SD, Lee TH, Goldhaber SZ. A critical pathway to treat proximal lower-extremity deep vein thrombosis. Am J Med. 1996;100:283-289.
10. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Intern Med. 1993;119:874-881.
11. Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med. 1995;123:941-948.
12. Falconer JA, Roth EJ, Sutin JA, Strasser DC, Chang RW. The critical path method in stroke rehabilitation. QRB Qual Rev Bull. 1993;19:8-16.
13. Brown PD, Lemer SA. Community-acquired pneumonia. Lancet. 1998;352:1295-1302.
14. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules JAMA. 1997;277:488-494.
15. Isaacson DM, Fernandez JA, Frosco M, et al. Levofloxacin: a review of its antibacterial activity. Recent Res Dev Antimicrob Agents Chemother. 1996; 1:391-439.
16. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: an observational study. BMJ. 1998;317:858-861.
17. Fine M, Auble T, Yealy D, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-250.
18. File T, Segretti J, Dunbar L, et al. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agents Chemother. 1997;41:1965-1972.
19. Meehan TP, Fine MJ, Krumholz HM, et al Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080-2084.
20. Fine MJ, Medsger AR, Stone RA, et al. The hospital discharge decision for patients with community-acquired pneumonia. Arch Intern Med. 1997;157:47-56.
21. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, Mass: Health Institute; 1994.
22. Metlay JP, Fine MJ, Schulz R, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med. 1997;12:423-430.
23. Guest JF, Morris A. Community-acquired pneumonia. Eur Respir J. 1997;10:1530-1534.
24. Ware JH, Antman EM. Equivalence trials. N Engl J Med. 1997;337:1159-1161.
25. Mann HB, Whitney DR. On a test whether one of two random variables is stochastically larger than the other. Ann Math Stat. 1947;18:50-60.
26. Donner A, Brown KS, Brasher P. A methodological review of non-therapeutic intervention trials employing cluster randomization, 1979-1989. Int J Epidemiol. 1990;19:795-800.
27. Diehr P, Martin DC, Koepsell T, Cheadle A. Breaking the matches in a paired t-test for community interventions when the number of pairs is small. Stat Med. 1995;14:1491-1504.
28. O'Doherty B, Dutchman DA, Pettit R, Maroli A. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. J Antimicrob Chemother. 1997;40(suppl A):73-81.
29. Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? N Engl J Med. 1996;334:1441-1447.
30. Philbin EF, DiSalvo TG. Managed care for congestive heart failure. Am Heart J. 1998;136:553-561.
31. Glick HA, Polsky D, Willke RJ, Alves WM, Kassell N, Schulman K. Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States. Stroke, 1998;29:351-358.
32. Townsend J, Piper M, Frank AO, Dyer S, North WRS, Meade TW. Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme. BMJ. 1988;297:544-547.
33. 1994 National Hospital Discharge Survey [CD-ROM]. Series 13, No. 12. Atlanta, Ga: Centers for Disease Control and Prevention; 1997.
34. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-1195.
35. Donner A, Klar N. Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol. 1996;49:435-439.